D. Medical issued U.S. patent

D. Medical Industries (NASDAQ, TASE:DMED) has been granted a U.S. patent, entitled “Devices For Continuous Measurement of Glucose in Body Fluid,” which protects innovative technology that allows for the combination of a minimally invasive continuous glucose monitor and an insulin pump on the same “patch.”

Among other features, the technology enables the use of a single access point to both accurately test for blood glucose levels and deliver insulin.

“The ability to accurately monitor glucose levels and deliver insulin via a single device employing a common insertion point represents a major breakthrough in the delivery of a safe, convenient and minimally invasive experience for insulin pump users,” COO Hezkiah Tsoory said in a statement.

“As we continue to develop our product pipeline for commercialization, it is important that the innovations that will define these future products are well protected,” he said, adding that the new patent “serves again to strengthen D. Medical’s already formidable intellectual property estate.”